Background Sinking prebeta lipoprotein is a putative marker for elevated levels of lipoprotein (a). Although prospective data suggest that increased plasma lipoprotein (a) is an independent risk factor for coronary heart disease in men, no prospective studies are available in women.
Methods and Results From 1968 through 1975, sinking prebeta lipoprotein was determined by paper electrophoresis in 3103 women Framingham Heart Study participants who were free of prevalent cardiovascular disease. A sinking prebeta lipoprotein band was detectable in 434 of the women (14%) studied. The median follow-up interval was approximately 12 years. Incident cardiovascular disease was associated with band presence using a proportional hazards model that included age, smoking, body mass index, systolic blood pressure, glucose intolerance, low-and high-density lipoprotein cholesterol, and ECG left ventricular hypertrophy. Multivariable adjusted relative risk estimates (with 95% confidence intervals) for outcomes in the band present versus absent groups were as follows: myocardial infarction (82 events), 2.37 I n 1963, Bergl discovered an antigenic determinant present in the low-density lipoprotein (LDL) fraction of some individuals and named it lipoprotein (a) [Lp(a)]. By 1974, several independent groups had reported the presence of an electrophoretic band in the density >1.006 g/mL fraction with prebeta mobility (hence the term "sinking prebeta") on paper,2 cellulose acetate,3 or agarose. 4 Early comparative studies2,5-7 using antisera provided by Berg strongly suggested that these sinking prebeta bands represented Lp(a); definitive confirmation was recently provided by Kawakami et a18 using the capillary transferable blotting method, followed by an enzyme-linked immunosorbent staining assay.
Data derived from studies using crude rabbit antisera immunoassays alone or in combination with the presence or absence of an extra or sinking prebeta band indicated that Lp(a) was a qualitative, autosomal dominant genetic marker present in as many as 35% of Caucasian populations.2,3'9'10 The advent of more refined immunoassays4,11 made it apparent that Lp(a) was a quantitative, not a qualitative trait, and that sinking prebeta positivity on electrophoresis generally corresponded to quantitative Lp(a) levels of >20 to 30 mg/dL.6'12'13 Although similar to LDL in core lipid composition and having B-100 as a surface apolipoprotein (apo), Lp(a) became recognized as a separate lipoprotein class [ie, Lp(a) ] that also contained the unique glycoprotein apo (a), probably disulfide-linked to apo B-100. 14, 15 Investigations from the 1970s suggested that the presence of an "additional"3 (equivalently, "sinking"16,17) prebeta band on cellulose acetate or agarose gels was linked to coronary heart disease (CHD) in men. Case-control studies using quantitative immunoassays confirmed these initial observations, demonstrating that men with Lp(a) levels >30 mg/dL were at significantly increased risk for CHD. 18 Results Quantitative Lp(a) data were available from a large subset of the study population (n= 1340). The distributions (see Fig 1) and mean plasma Lp(a) levels (±SEM) in the pooled definite or trace (n= 169) group (39.9+1.6 mg/dL) were significantly different from those in the absent (n=1171) group (11.9±0.4; P<.0001 by t test). Lp(a) concentrations of >38 mg/dL are above the 90th Table  3 shows the absolute number of events, the unadjusted incidence densities per 1000 person-years of follow-up, and crude relative risk estimates (ie, hazards ratios, band present divided by band absent) for myocardial infarction, intermittent claudication, total cerebrovascular disease, total CHD, and total CVD. An ageadjusted Kaplan-Meier plot with myocardial infarction as the outcome is illustrated in Fig 2 Table 4 reveal that for myocardial infarction, sinking prebeta lipoprotein band presence was associated with a population attributable risk percentage (17.6%) essentially equivalent to elevated total cholesterol (18.7%) and a low HDL cholesterol defined as <45 mg/dL (18.8%).
Discussion
Our data confirm previous reports6,8,12'13 that the detection of a prebeta migrating band during electrophoresis of density >1.006 g/mL plasma is a valid surrogate for substantially increased Lp(a) levels. The analyses are unique in providing the first prospective evidence that elevated plasma Lp(a) detected by electrophoresis is an independent risk factor for CHD in women. In addition, we report the first prospective association between elevated Lp(a) and non-CHD atherothrombotic sequelae, ie, intermittent claudication and cerebrovascular disease.
We validated sinking prebeta lipoprotein band presence as a surrogate for elevated plasma Lp(a) by comparing quantitative Lp(a) levels determined during Offspring examination 3 (1984 through 1987) with band presence or absence at Offspring examination 1 (1971 through 1975). Despite the difference in sampling dates, Lp(a) concentrations, in contrast to LDL and apo B, appear to remain constant over time and are largely independent of age.5560, 61 In summary, detection of a sinking prebeta lipoprotein band on electrophoresis was a valid marker for elevated Lp(a) levels in Framingham Heart Study women who were free of prevalent CVD. Band presence and, equivalently, elevated plasma Lp(a) predicted the development of atherothrombotic outcomes, especially myocardial infarction, in these women. Confirmation of these findings in other longitudinal studies of women is needed.
